Abstract
Following retroperitoneal, intradermal inoculation of mice with HSV-1, signs of encephalomyelitis (hind-limb paralysis, flaccid tail and loss of bladder control) appeared 6–7 days later. Levels of quinolinic acid (QUIN; determined by gas chromatography with mass-spectrometry), rose approximately 40-fold in mice with encephalomyelitis, primarily in the spinal cord. Live virus could also be grown from homogenates of the affected spinal cords. Time-course studies, demonstrated that the increase in QUIN coincided with the appearance of encephalomyelitis. Large increases in indoleamine dioxygenase activity were observed in spinal cords from the affected mice, suggesting that the QUIN was synthesized within the spinal cord. It is, therefore, possible that QUIN may contribute to the pathology of HSV-1 encephalomyelitis.
Keywords
- Spinal Cord
- Herpes Simplex Virus Type
- Fibroblast Growth Factor Receptor
- Quinolinic Acid
- Herpes Simplex Virus Encephalitis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
Anderson J.R., Field H.J., 1983, The distribution of herpes simplex virus type 1 antigen in mouse central nervous system after different routes of inoculation. J Neurol Sci60:181.
Blight A.R., Saito K., Heyes M.P., 1993, Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury. Brain Res632:314.
Dillard S.H., Cheatham W.J., Moses H.L., 1995, Electron microscopy of zosteriform herpes simplex virus infection in the mouse. Lab Invest1972:391.
Erickson J.B., Flanagan E.M., Russo S., Reinhard J.F., Jr., 1992, A radiometric assay for kynurenine 3-hy- droxylase based on the release of 3H20 during hydroxylation of L-[3,5-3H]Kynurenine. Anal Biochem205:257.
Flanagan E.M., Erickson J.B., Viveros O.H., Chang S.Y., Reinhard J.F.,Jr., 1995, Neurotoxin quinolinic acid is selectively elevated in the spinal cords of rats with experimental allergic encephalomyelitis. J Neurochem64:1192.
Foster A.C., Miller L.R, Oldendorf W.H., Schwarcz R., 1984, Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat. Exp Neurol84:428.
Giulian D., Corpuz M., Chapman S., Mansouri M., Robertson C., 1993, Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J. Neuroscience Res.36:681.
Heyes M.R, Markey S.R, 1988, Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry:effects of systemic L-trypto- phan administration on brain and blood quinolinic acid concentrations. Anal Biochem174:349.
Heyes M.R, Rubinow D., Lane C., Markey S.R, 1989, Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Ann Neurol26:275.
Heyes M.R, Saito K., Markey S.R, 1992a, Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem J283:633.
Heyes M.R, Saito K., Jacobowitz D., Markey S.R, Takikawa O., Vickers J.H., 1992b, Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain. FASEB J6:2977.
Heyes M.R, Saito K., Major E.O., Milstien S., Markey S.R, Vickers J.H., 1993, A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain116:1425.
Kaner R.J., Baird A., Mansukhani A., et al., 1990, Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type 1.. Science248:1410.
Kristensson K., Vahlne A., Persson L.A., Lycke E., 1978, Neuronal spread of herpes simplex vims types 1 and 2 after corneal or subcutaneous (footpad) inoculation. J Neurol Sci35:331.
Meyer H.M., Jr, Johnson R.T., Crawford I.P., Dascomb H.E., Rogers N.G., 1960, Central nervous system syndromes of “viral” aetiology-A study of 713 cases. Am J Med29:334.
Okuno E., Kido R., 1991, Kynureninase and Kynurenine 3-Hydroxylase in Mammalian Tissues. In:Kynurenine and Serotonin Pathways. Schwarcz R. ed. Plenum Press, New York, 167 - 176.
Okuno E., Kohler C., Schwarcz R., 1987, Rat 3-hydroxyanthranilic acid oxygenase:purification from the liver and immunocytochemical localization in the brain. J Neurochem49:771.
Popovitch P.G., Reinhard J.F.,Jr., Flanagan E.M., Stokes B.T., 1994, Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma. Brain Res633:348
Reinhard J.F.,Jr., Erickson J.B., Flanagan E.M.., 1994, Quinolinic acid in neurological disease:opportunities for novel drug discovery. Adv Pharmacol30:85.
Saito K., Crowley J.S., Markey S.P., Heyes M.P., 1993a, A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J Biol Chem. 268:15496.
Saito K., Nowak T.S.,Jr., Markey S.P., Heyes M.P., 1993b, Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J Neurochem60:180.
Werner Felmayer G., Werner E.R., Fuchs D., Hausen A., Reibnegger G., Wachter H., 1989, Characteristics of interferon induced tryptophan metabolism in human cells in vitro. Biochim Biophys Acta1012:140.
Whetsell W.O.J., Schwarcz R., 1989, Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett97:271.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Reinhard, J.F., Flanagan, E.M. (1996). The Neurotoxin Quinolinic Acid is Increased in Spinal Cords of Mice with Herpes Simplex Virus Encephalitis. In: Filippini, G.A., Costa, C.V.L., Bertazzo, A. (eds) Recent Advances in Tryptophan Research. Advances in Experimental Medicine and Biology, vol 398. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0381-7_37
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0381-7_37
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8026-9
Online ISBN: 978-1-4613-0381-7
eBook Packages: Springer Book Archive